Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2021-02-25 2021-01-22
Drug Identification Number 00653233 00653233
Brand name TEVA-LENOLTEC NO. 1 TEVA-LENOLTEC NO. 1
Common or Proper name LENOLTEC NO.1 CAPLET LENOLTEC NO.1 CAPLET
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients ACETAMINOPHEN CAFFEINE CODEINE PHOSPHATE ACETAMINOPHEN CAFFEINE CODEINE PHOSPHATE
Strength(s) 300MG 15MG 8MG 300MG 15MG 8MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 200 200
ATC code N02AJ N02AJ
ATC description OPIOIDS OPIOIDS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-01-20 2021-01-20
Estimated end date 2021-02-28 2021-02-28
Actual end date 2021-02-24
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments